seed
Stage
1
Investors
About
AtriAN Medical develops a cardiac treatment technology that uses pulsed field ablation to selectively disable cardiac autonomic neurons on the heart's epicardial surface to provide a safer, more durable therapy for atrial fibrillation.
Explore AtriAN Medical's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.